Drug Shortage Report for TELMISARTAN HCTZ
| Report ID | 211171 |
| Drug Identification Number | 02390302 |
| Brand name | TELMISARTAN HCTZ |
| Common or Proper name | Telmisartan HCTZ |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE TELMISARTAN |
| Strength(s) | 12.5MG 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-05-15 |
| Estimated end date | 2024-02-02 |
| Actual end date | 2024-02-02 |
| Shortage status | Resolved |
| Updated date | 2024-02-03 |
| Company comments | Changing supplier |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-02-03 | English | Compare |
| v4 | 2024-02-02 | French | Compare |
| v3 | 2024-02-02 | English | Compare |
| v2 | 2023-11-22 | French | Compare |
| v1 | 2023-11-22 | English | Compare |
Showing 1 to 5 of 5